GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Current antiviral treatment for chronic hepatitis B is effective ... On one hand, future drugs should have improved tolerability and durability. Treatment that can increase the chance of HBsAg ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...